Higher Serum CCN3 Is Associated with Disease Activity and Inflammatory Markers in Rheumatoid Arthritis
Open Access
- 9 May 2020
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2020, 1-7
Abstract
Nephroblastoma overexpressed protein (NOV/CCN3), the early discovered member of the CCN family, has recently been suggested to be involved in a number of inflammatory processes, including wound healing, alveolar epithelial cell inflammation, cancer metastasis, and macrophage foam cell formation. However, the role of CCN3 in rheumatoid arthritis (RA), a classic autoimmune and inflammatory disease, remains elusive. RA is a chronic systemic autoimmune disease that eventually leads to cartilage and bone destruction and joint dysfunction. In this study, we investigated the potential of serum CCN3 as a biomarker for RA. The serum levels of CCN3 were measured by ELISA. The clinical and laboratory parameters were collected from a clinical record system, and disease activity was determined by joint disease activity score 28 (DAS28). Our results showed that the serum levels of CCN3 were significantly increased in RA patients compared to healthy controls. Furthermore, the CCN3 level was positively correlated with DAS28 (CRP), DAS28 (ESR), and the level of anti-CCP Ab, an autoantibody highly specific for RA. Furthermore, CCN3 showed a positive correlation with inflammatory cytokine IL-6, while no significant correlation with TNF-α was observed. These data suggest that CCN3 plays an important role in the development of RA and might be a potential disease activity biomarker for RA.Keywords
Funding Information
- Jiangxi Provincial People’s Hospital (19-008, 20192ACB21006, 81670431, 81671544, 81960296, 81974254, 81871286)
- Natural Science Foundation of Jiangxi Province (19-008, 20192ACB21006, 81670431, 81671544, 81960296, 81974254, 81871286)
- National Natural Science Foundation of China (19-008, 20192ACB21006, 81670431, 81671544, 81960296, 81974254, 81871286)
- National Natural Science Foundation of China (19-008, 20192ACB21006, 81670431, 81671544, 81960296, 81974254, 81871286)
- National Natural Science Foundation of China (19-008, 20192ACB21006, 81670431, 81671544, 81960296, 81974254, 81871286)
- National Natural Science Foundation of China (19-008, 20192ACB21006, 81670431, 81671544, 81960296, 81974254, 81871286)
- National Natural Science Foundation of China (19-008, 20192ACB21006, 81670431, 81671544, 81960296, 81974254, 81871286)
This publication has 33 references indexed in Scilit:
- Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic DisordersPLOS ONE, 2013
- NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9Journal of Neuroinflammation, 2012
- Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsNature Reviews Drug Discovery, 2011
- Cell and cytokine imbalances in rheumatoid synovitisJoint Bone Spine, 2011
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammationNature Immunology, 2011
- CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal DiseaseThe American Journal of Pathology, 2009
- Shifting the imbalance from Th1/Th2 to Th17/treg: The changing rheumatoid arthritis paradigmJoint Bone Spine, 2008
- Integrin-dependent Functions of the Angiogenic Inducer NOV (CCN3)Journal of Biological Chemistry, 2005
- CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein FamilyJournal of Biological Chemistry, 2003
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988